Aetna, Humana Agree to Sell Assets to Win Merger Approval

The transcript discusses a legal case involving a potential merger and its implications on Medicare Advantage and traditional Medicare. The DOJ's stance on market competition is highlighted, along with arguments against market consolidation. The impact of the merger on local healthcare is debated, and the potential sale of assets to Molina Healthcare is explored as a strategy to address DOJ concerns.

What is the main argument the company plans to present to the judge regarding Medicare Advantage and traditional Medicare?

• They are the same market.

• They are separate markets and do not compete.

• They are both controlled by the DOJ.

• They require divestitures to compete.

What is the company's strategy to address market competition concerns?

• Merge with another large insurer.

• Create a new competitor by divesting certain markets.

• Increase prices to reduce competition.

• Focus solely on the commercial market.

How does the company differentiate its case from the Anthem-Cigna merger?

• By emphasizing local market competition.

• By increasing national market share.

• By focusing on the commercial market.

• By merging with a Blue Cross Blue Shield plan.

What is the expected national market share of the merged company?

• 10%

• 90%

• 25%

• 50%

What role does Moody's Investors Service play in the merger process?

• They are responsible for divesting markets.

• They are a competitor in the Medicare market.

• They are part of the DOJ.

• They provide a probability assessment of the merger's approval.